Table 2:

Predictors of recurrent CDI among patients with diagnosis of CDI

CovariateRecurrence type; adjusted HR (95% CI)*
First recurrenceSecond recurrence
Age, yr (Ref: 18–69 yr)
 70–791.51 (1.27 to 1.79)1.61 (1.14 to 2.28)
 ≥ 802.01 (1.72 to 2.34)2.76 (2.06 to 3.70)
Female sex (v. male)1.16 (1.02 to 1.32)0.99 (0.78 to 1.25)
SEFI (Ref: richer v. poorer)0.92 (0.82 to 1.04)0.98 (0.78 to 1.23)
CCI (Ref: 0)§
 11.23 (1.02 to 1.47)0.83 (0.57 to 1.20)
 21.17 (0.96 to 1.42)1.35 (0.96 to 1.91)
 ≥ 31.18 (0.97 to 1.45)1.23 (0.84 to 1.78)
Diabetes (v. none)1.06 (0.91 to 1.23)1.00 (0.76 to 1.31)
Renal disease (v. none)1.07 (0.89 to 1.30)1.17 (0.84 to 1.63)
IBD (v. none)1.13 (0.79 to 1.63)0.81 (0.36 to 1.83)
Ambulatory care visits in prior year (v. most)
 Least1.17 (0.96 to 1.43)1.93 (1.20 to 3.11)
 Quartile 21.20 (0.97 to 1.48)1.92 (1.21 to 3.05)
 Quartile 31.10 (0.88 to 1.38)2.12 (1.37 to 3.27)
CDI subtype (v. community-associated)
 HCF-onset HCF-associated1.20 (1.02 to 1.42)1.28 (0.91 to 1.79)
 Community-onset HCF-associated1.25 (1.03 to 1.53)1.51 (1.03 to 2.21)
 Indeterminate1.18 (0.93 to 1.50)1.34 (0.86 to 2.11)
  • Note: CDI = Clostridioides difficile infection, CCI = Charlson Comorbidity Index, CI = confidence interval, HCF = health care facility, HR = hazard ratio, IBD = inflammatory bowel disease, Ref = Reference, SEFI = Socioeconomic Factor Index.

  • * HRs were adjusted for all factors listed in table.

  • For the first recurrence analysis, we included 5795 incident CDIs with > 14 days follow-up. There were 1021 recurrences (events) and 421 deaths (competing events).

  • For the second recurrence analysis, we included 5558 incident CDIs with > 28 day follow-up. There were 295 recurrences (events) and 500 deaths (competing events).

  • § Renal disease and diabetes omitted from CCI calculation.

  • In the subgroup analysis of those with HCF-onset HCF-associated CDI (n = 2338), longer hospitalization (> 14 days) before CDI onset was associated with increased risk of both first CDI recurrence (n = 477; HR 1.70 [95% CI 1.40 to 2.06]) as well as the second CDI recurrence (n = 142; HR 1.76 [95% CI 1.23 to 2.52]).